Literature DB >> 2715212

Cerebral blood flow before and after cardioversion of atrial fibrillation.

P Petersen1, J Kastrup, R Videbaek, G Boysen.   

Abstract

In nine patients with atrial fibrillation (AF) of less than 3 months' duration, CBF was measured the day before and after and again 30 days after electrical cardioversion therapy to sinus rhythm. The day before cardioversion therapy, median CBF (expressed as initial slope index 1, ml/100 g.min-1) was 35.8 and the day after it was 37.1. After 30 days in sinus rhythm, CBF was 39.4 (NS), although the end-tidal PCO2 values were lower than the pretreatment values. After correction for changes in end-tidal PCO2, the median CBF had increased significantly from 35.8 to 40.3 on day 1 and to 46.7 on day 30. The reduced CBF during AF could be a contributing factor in the development of cerebrovascular complications in patients with AF.

Entities:  

Mesh:

Year:  1989        PMID: 2715212     DOI: 10.1038/jcbfm.1989.62

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  28 in total

1.  The cognitive impact of atrial fibrillation.

Authors:  Anne F Gross; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-01-10

2.  Case report: regional cerebral hypoperfusion induced by ventricular tachycardia - short-term hippocampal hypoperfusion and its potential relationship to selective neuronal damage.

Authors:  A Hagendorff; E Klemm; M Bangard; C Dettmers; C Wolpert; B Schumacher; H J Biersack; F Grünwald; B Lüderitz; D Pfeiffer
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

3.  Atrial fibrillation and risk of dementia: a prospective cohort study.

Authors:  Sascha Dublin; Melissa L Anderson; Sebastien J Haneuse; Susan R Heckbert; Paul K Crane; John C S Breitner; Wayne McCormick; James D Bowen; Linda Teri; Susan M McCurry; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2011-08-01       Impact factor: 5.562

4.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

5.  Neuroanatomical correlates of atrial fibrillation: a longitudinal MRI study.

Authors:  Adnan I Qureshi; Aveen Saed; Nudrat Tasneem; Malik M Adil
Journal:  J Vasc Interv Neurol       Date:  2014-12

6.  Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort.

Authors:  Sascha Dublin; Melissa L Anderson; Susan R Heckbert; Rebecca A Hubbard; Joshua A Sonnen; Paul K Crane; Thomas J Montine; Eric B Larson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-09-28       Impact factor: 6.053

7.  Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.

Authors:  Z Yuan; S Bowlin; D Einstadter; R D Cebul; A R Conners; A A Rimm
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

Review 8.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

9.  Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts.

Authors:  Hrafnhildur Stefansdottir; David O Arnar; Thor Aspelund; Sigurdur Sigurdsson; Maria K Jonsdottir; Haukur Hjaltason; Lenore J Launer; Vilmundur Gudnason
Journal:  Stroke       Date:  2013-02-26       Impact factor: 7.914

Review 10.  The impact of atrial fibrillation and its treatment on dementia.

Authors:  Arun Kanmanthareddy; Ajay Vallakati; Arun Sridhar; Madhu Reddy; Hari Priya Sanjani; Jayasree Pillarisetti; Donita Atkins; Sudharani Bommana; Misty Jaeger; Loren Berenbom; Dhanunjaya Lakkireddy
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.